James New

James New

Director Ejecutivo en
Wavodyne Therapeutics, Inc.
.
72 años
Health Technology
Consumer Services
Commercial Services

Perfil

James New is the founder of Wavodyne Therapeutics, Inc. Former positions include Chief Executive Officer at Abrika Pharmaceuticals LLP from 2002 to 2007, President & Chief Executive Officer at Veloxis Pharmaceuticals A from 2008 to 2009, Chief Executive Officer at AIKO Biotechnology, Inc., President & Chief Executive Officer at Synaptogenix, Inc. in 2014, Director at Neurotrope, Inc. in 2014, Principal at Bristol Myers Squibb Co. from 1980 to 1992, Principal at Pfizer Inc. from 1994 to 1999, Principal at Novartis AG from 1999 to 2001, and Principal at GSK Plc.
Education includes an undergraduate degree from State University of New York College at Geneseo, a doctorate from State University of New York at Buffalo, a graduate degree from the University of Maine, and an MBA from Columbia Business School.

Cargos activos de James New

EmpresasCargoInicio
Director Ejecutivo -

Antiguos cargos conocidos de James New.

EmpresasCargoFin
NEUROTROPE, INC. Director Ejecutivo 16/07/2014
SYNAPTOGENIX, INC. Director Ejecutivo 16/07/2014
VELOXIS PHARMACEUTICALS A/S Director Ejecutivo 01/01/2009
Director Ejecutivo 01/01/2007
NOVARTIS AG Corporate Officer/Principal -
Ver el detalle de la experiencia de James New.

Formación de James New.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

77

Relaciones de 1er grado

14

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas14

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Technology Services

Consumer Services

Health Technology